Manuel
Barreiro de Acosta
Complexo Hospitalario Universitario da Coruña
La Coruña, EspañaPublicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario da Coruña (9)
2024
-
Efficacy and safety of biological treatment for inflammatory bowel disease in elderly patients: Results from a GETECCU cohort
Gastroenterologia y Hepatologia
-
Long-term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study
Alimentary Pharmacology and Therapeutics, Vol. 60, Núm. 10, pp. 1325-1338
2023
-
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
American Journal of Gastroenterology, Vol. 118, Núm. 7, pp. 1237-1247
2021
-
Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study
European Journal of Clinical Nutrition, Vol. 75, Núm. 9, pp. 1368-1382
2018
-
Addition of granulocyte/monocyte apheresis to oral prednisone for steroid-dependent ulcerative colitis: A Randomized multicentre clinical trial
Journal of Crohn's and Colitis, Vol. 12, Núm. 6, pp. 687-694
2016
-
Impact of smoking cessation on the clinical course of Crohn's disease under current therapeutic algorithms: A multicenter prospective study
American Journal of Gastroenterology, Vol. 111, Núm. 3, pp. 411-419
-
Tuberculosis in anti-tumour necrosis factortreated inflammatory bowel disease patients after the implementation of preventive measures: Compliance with recommendations and safety of retreatment
Journal of Crohn's and Colitis, Vol. 10, Núm. 10
-
Urine metabolome profiling of immune-mediated inflammatory diseases
BMC Medicine, Vol. 14, Núm. 1
2013
-
High smoking cessation rate in Crohn's disease patients after physician advice - The TABACROHN Study
Journal of Crohn's and Colitis, Vol. 7, Núm. 3, pp. 202-207